Obesity Medicine Resources
Helpful Resources to Support Your Practice
Evidence-based obesity medicine research
Obesity Pillars® Journal
Our medical journal is dedicated to publishing evidence-based research for health care clinicians in the field of obesity medicine. Obesity Pillars® serves as a resource to assist clinicians to deliver patient-centered obesity medicine care in alignment with the OMA’s four pillars of obesity treatment: Nutrition Therapy, Physical Activity, Behavioral Modification, and Medical Interventions.

Obesity Algorithm
The Obesity Algorithm® is a comprehensive clinical tool designed to guide healthcare professionals in the assessment and management of obesity. This algorithm provides a structured framework for evaluating patients with obesity, offering a step-by-step approach to diagnosis, treatment, and ongoing care. The Obesity Algorithm is regularly updated to reflect the latest research and clinical guidelines.

Pediatric Obesity Algorithm
The Pediatric Obesity Algorithm® offers healthcare providers a structured approach for managing overweight and obesity in children and adolescents. This evidence-based tool draws from scientific research, medical knowledge, and the practical insights of pediatric clinicians who regularly address weight-related issues in young patients.

OMA Academy
Customize your obesity medicine education and access the entire on-demand library of CME, ABOM Exam study materials, handouts, and other practical resources in the Obesity Medicine Academy.

Pediatric Resources
OMA's pediatric resources encompass a wealth of educational materials, clinical guidelines, and research-based insights to aid healthcare professionals in effectively managing and preventing obesity in children and adolescents. OMA's commitment to combating pediatric obesity is reflected in its extensive pediatric-focused resources, empowering healthcare professionals to make a meaningful impact on the health and well-being of young patients.
OMA Blog

It’s Time to Change the Way We Treat Obesity and Provide Access to Care
We need an operation warp speed for obesity medicine. Healthcare systems , insurers, and employers are still falling short on our mission of radically changing what obesity looks like in the U.S. and providing access to the full suite of effective obesity treatment interventions including medications that are proven to help patients manage their condition.

Cardiovascular Benefits of Treating Obesity: Practical Approaches for Physicians
Although cardiovascular disease remains a significant concern, many of its risk factors can be managed, and in some cases, even reversed. One of the most effective ways to support heart health is through weight loss.

Not All Obesity is the Same: Rare Genetic Forms of Obesity
1 On the other hand, there are other rare types of obesities resulting from some rare but highly impactful genetic variants or deletions (i.e. Bardet- Biedl Syndrome, POMC deficiency, LEPR deficiency, Prader-Willi Syndrome), or even acquired hypothalamic damage (i.e. acquired hypothalamic obesity) ( Figure 1). Rare genetic variants or damage to the hypothalamus can lead to impairment of a critical pathway, the hypothalamic melanocortin-4 receptor (MC4R) pathway, otherwise known as the leptin-melanocortin pathway. This pathway is responsible for regulating hunger and energy expenditure and any impairment in the pathway leads to rare MC4R pathway diseases. 2-3 It is important to be aware of this unique subset of obesity associated with MC4R pathway diseases as MC4R pathway diseases are likely underdiagnosed and early identification of MC4R pathway diseases is essential for optimal disease management. 4-6 Figure 1: Rare Hypothalamic MC4R Pathway Diseases The MC4R signaling pathway regulates hunger, satiety, and energy expenditure, consequently affecting body weight. 7-8 Genetic variants that impair function of genes involved in the MC4R Pathway function, or physical damage to the hypothalamus leads to decreased alpha-MSH and impaired downstream activation of the MC4R pathway. 9 Figure 2: Impairment of the MC4R Signaling Pathway MC4R pathway diseases caused by rare genetic variants are classified as monogenic or syndromic in nature. 10 Monogenic obesity refers to obesity due to variants in single genes (e.g. POMC deficiency, LEPR deficiency, PCSK1 deficiency, SRC1 deficiency, SH2B1 deficiency, etc.) along the MC4R pathway. Syndromic obesity refers to obesity that is also due to genetic variants or deletions in the pathway but also associated with additional phenotypes such as organ-specific developmental abnormalities, such as visual impairment, renal anomalies, cognitive impairment, dysmorphic features, etc. 10-11 Rare Genetic Diseases of Obesity Provider Listing A patient's diagnostic journey can be complex and may take years.

Official podcast of the OMA
Obesity: A Disease
Podcast episodes provide valuable insights into treating the disease of obesity and better equip clinicians to understand and engage in treating this disease.
Obesity Medicine Job Board
The OMA job board is a comprehensive, dynamic platform, and a valuable resource for job seekers. Discover diverse job listings from reputable organizations spanning industries such as technology, healthcare, psychology, and more. Users can browse through a variety of job postings, including full-time, part-time, remote, and internships, catering to a broad spectrum of career needs. The OMA job board also offers a job submission feature where users can submit their own job listings.